Advertisement

Topics

Goodwin Publishes Report on Significant Developments in Securities Litigation Against Life Sciences and Health Care Companies

11:28 EST 15 Feb 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Global 50 law firm Goodwin announced today the release of its 2017 Year In Review - Securities Litigation Against Life Sciences and Health Care Companies, a report drawing notable trends and insights from major securities class ...

Other Sources for this Article

Goodwin
Emily Nelson, 212-459-7424
enelson@goodwinlaw.com

NEXT ARTICLE

More From BioPortfolio on "Goodwin Publishes Report on Significant Developments in Securities Litigation Against Life Sciences and Health Care Companies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...